| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000027732 |
| Receipt No. | R000031763 |
| Official scientific title of the study | A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract including proteoglycan |
| Date of disclosure of the study information | 2017/06/13 |
| Last modified on | 2017/06/12 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract including proteoglycan | |
| Title of the study (Brief title) | A clinical study for evaluating the safety of excessive intake of salmon nasal cartilage extract | |
| Region |
|
|
| Condition | ||
| Condition | Healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To evaluate the safety of excessive intake of salmon nasal cartilage extract for 4 weeks in healthy adults. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Hematologic test
Biochemistry test Urinalysis Medical interview Adverse event |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | Consumption of salmon nasal cartilage extract,
5 fold quantity of recommended daily intake, for 4 weeks. |
|
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1) Healthy men and women.
2) Subjects giving written informed consent based on Declaration of Helsinki. 3) Subjects who can intake test food sample every day during test period. 4) Subjects who can attend to every examinations. |
|||
| Key exclusion criteria | 1) Subjects who take drugs or supplements
2) Subjects undergoing treatment for some serious disorders 3) Subjects who make a blood donation within the last month before and during the test 4) Women who are pregnant or breast-feeding 5) Subjects who have allergies to salmon, shrimp or crab 6) Subjects whose participation is deemed inappropriate by pilot questionnaire, clinical test values or physical exam values 7) Subjects who cannot follow a guideline of test 8) Subjects undergoing hormone replacement therapy 9) Subjects whose participation is deemed inappropriate by a test director |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Kazue Takayama |
| Organization | Ichimaru Pharcos Co., Ltd. |
| Division name | Product Development |
| Address | 318-1 Asagi, Motosu-Shi, Gifu 501-0475 Japan |
| TEL | 058-320-1036 |
| takayama-kazue@ichimaru.co.jp | |
| Public contact | |
| Name of contact person | Kazunori Enya |
| Organization | Ichimaru Pharcos Co., Ltd. |
| Division name | Product Development |
| Address | 318-1 Asagi, Motosu-Shi, Gifu 501-0475 Japan |
| TEL | 058-320-1037 |
| Homepage URL | |
| enya-kazunori@ichimaru.co.jp | |
| Sponsor | |
| Institute | Ichimaru Pharcos Co., Ltd. |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Ichimaru Pharcos Co., Ltd. |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 独立行政法人地域医療機能推進機構 可児とうのう病院 健康管理センター |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031763 |